Showing results (201-210 of 283) with videos related to

Sort By:
Pageof 29
Frontiers in Immunology|September 6, 2024
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective studyPatrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Journal of Medical Internet Research|May 20, 2021
A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) RegistryStefan Kleinert, Peter Bartz-Bazzanella, Cay von der Decken, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Autoimmunity Reviews|January 22, 2025
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Therapeutic Advances in Ophthalmology|November 4, 2024
Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-SjögrenMelanie Haar, Franz Felix Konen, Marten A Gehlhaar, et al.
Human Immunology|November 9, 2011
Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosusMaría Teruel, Jose-Ezequiel Martin, Norberto Ortego-Centeno, et al.
Frontiers in Immunology|June 7, 2024
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR databasePatrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, et al.
Annals of the Rheumatic Diseases|October 27, 2023
Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centresMatthias Dreher, Torsten Witte, Kirsten Hoeper, et al.
Rheumatology International|August 13, 2024
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR networkPatrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, et al.
Pageof 29